Better Obesity Drug Race: Novo Nordisk vs Lilly 2026
In the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
Understanding what not to do when budgeting is crucial for financial success. Learn the common mistakes to steer clear of.
25,899 articlesIn the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
With crude hovering near $70, some investors wonder if energy stocks can keep delivering. This article explains why t...
VanEck's GENZ pivots from casino-heavy holdings to growth stocks like Uber and NetEase, reshaping its dividend story ...
As rates shift and banks adjust to a new credit environment, PFF remains the dominant preferred-stock ETF with a siza...
Ripple’s emeritus CTO outlines a reservation-based fix for XRPL front-running on the DEX/AMM, setting up a high-stake...
The Army announces a framework allowing private funds to finance and operate base infrastructure, signaling a major s...
Ouster and Aeva powered higher in a Tuesday session, as investors priced in a new wave of demand for physical AI lida...
Two fast-casual leaders are vying for investor attention in 2026. This deep dive compares CAVA Group and Chipotle Mex...
Ark Invest discloses a fresh Palantir stake as AI momentum collides with higher yields, prompting debate over whether...
Palantir surged about 9% after announcing a Sovereign-AI partnership with NVIDIA, aimed at secure, air-gapped governm...
S&P Global recently completed a strategic spin-off, triggering a near 8% jump in the parent stock. Here’s what happen...
Billionaire investor Michael Burry has lodged a new tesla short bet, intensifying the debate over Tesla’s robotics pu...